nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0467	0.0573	CbGbCtD
Halofantrine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0423	0.0518	CbGbCtD
Halofantrine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0423	0.0518	CbGbCtD
Halofantrine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0406	0.0498	CbGbCtD
Halofantrine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0406	0.0498	CbGbCtD
Halofantrine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0365	0.0447	CbGbCtD
Halofantrine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0354	0.0434	CbGbCtD
Halofantrine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.032	0.0392	CbGbCtD
Halofantrine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.032	0.0392	CbGbCtD
Halofantrine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0308	0.0377	CbGbCtD
Halofantrine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0308	0.0377	CbGbCtD
Halofantrine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0305	0.0373	CbGbCtD
Halofantrine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0295	0.0362	CbGbCtD
Halofantrine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0287	0.0351	CbGbCtD
Halofantrine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0287	0.0351	CbGbCtD
Halofantrine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0259	0.0318	CbGbCtD
Halofantrine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0259	0.0318	CbGbCtD
Halofantrine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0224	0.0274	CbGbCtD
Halofantrine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0217	0.0266	CbGbCtD
Halofantrine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0196	0.0241	CbGbCtD
Halofantrine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0196	0.0241	CbGbCtD
Halofantrine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0194	0.0237	CbGbCtD
Halofantrine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0182	0.0223	CbGbCtD
Halofantrine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0182	0.0223	CbGbCtD
Halofantrine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0165	0.0202	CbGbCtD
Halofantrine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0165	0.0202	CbGbCtD
Halofantrine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0142	0.0174	CbGbCtD
Halofantrine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0138	0.0169	CbGbCtD
Halofantrine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0125	0.0153	CbGbCtD
Halofantrine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0125	0.0153	CbGbCtD
Halofantrine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.012	0.0147	CbGbCtD
Halofantrine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00238	CcSEcCtD
Halofantrine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00043	0.00238	CcSEcCtD
Halofantrine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000428	0.00237	CcSEcCtD
Halofantrine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.000427	0.00236	CcSEcCtD
Halofantrine—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000426	0.00236	CcSEcCtD
Halofantrine—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000426	0.00236	CcSEcCtD
Halofantrine—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00235	CcSEcCtD
Halofantrine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000425	0.00235	CcSEcCtD
Halofantrine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000424	0.00235	CcSEcCtD
Halofantrine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00234	CcSEcCtD
Halofantrine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000422	0.00233	CcSEcCtD
Halofantrine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00042	0.00233	CcSEcCtD
Halofantrine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00042	0.00232	CcSEcCtD
Halofantrine—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000419	0.00232	CcSEcCtD
Halofantrine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000418	0.00231	CcSEcCtD
Halofantrine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000416	0.00231	CcSEcCtD
Halofantrine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000414	0.00229	CcSEcCtD
Halofantrine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000413	0.00229	CcSEcCtD
Halofantrine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000412	0.00228	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000412	0.00228	CcSEcCtD
Halofantrine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000412	0.00228	CcSEcCtD
Halofantrine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.00228	CcSEcCtD
Halofantrine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000411	0.00228	CcSEcCtD
Halofantrine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00041	0.00227	CcSEcCtD
Halofantrine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000409	0.00227	CcSEcCtD
Halofantrine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000407	0.00226	CcSEcCtD
Halofantrine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000407	0.00225	CcSEcCtD
Halofantrine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.00225	CcSEcCtD
Halofantrine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00225	CcSEcCtD
Halofantrine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000405	0.00224	CcSEcCtD
Halofantrine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000401	0.00222	CcSEcCtD
Halofantrine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000401	0.00222	CcSEcCtD
Halofantrine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.0004	0.00222	CcSEcCtD
Halofantrine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.00221	CcSEcCtD
Halofantrine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.0022	CcSEcCtD
Halofantrine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00219	CcSEcCtD
Halofantrine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00219	CcSEcCtD
Halofantrine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000396	0.00219	CcSEcCtD
Halofantrine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000393	0.00217	CcSEcCtD
Halofantrine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000392	0.00217	CcSEcCtD
Halofantrine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00039	0.00216	CcSEcCtD
Halofantrine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00039	0.00216	CcSEcCtD
Halofantrine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000388	0.00215	CcSEcCtD
Halofantrine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000386	0.00214	CcSEcCtD
Halofantrine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000386	0.00214	CcSEcCtD
Halofantrine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.00213	CcSEcCtD
Halofantrine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000383	0.00212	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000383	0.00212	CcSEcCtD
Halofantrine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000382	0.00212	CcSEcCtD
Halofantrine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000381	0.00211	CcSEcCtD
Halofantrine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000381	0.00211	CcSEcCtD
Halofantrine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00211	CcSEcCtD
Halofantrine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.0021	CcSEcCtD
Halofantrine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000378	0.00209	CcSEcCtD
Halofantrine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000377	0.00209	CcSEcCtD
Halofantrine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000377	0.00209	CcSEcCtD
Halofantrine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000376	0.00208	CcSEcCtD
Halofantrine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000375	0.00208	CcSEcCtD
Halofantrine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000374	0.00207	CcSEcCtD
Halofantrine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000374	0.00207	CcSEcCtD
Halofantrine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000373	0.00207	CcSEcCtD
Halofantrine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000373	0.00206	CcSEcCtD
Halofantrine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00206	CcSEcCtD
Halofantrine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00205	CcSEcCtD
Halofantrine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00205	CcSEcCtD
Halofantrine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000369	0.00204	CcSEcCtD
Halofantrine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.00204	CcSEcCtD
Halofantrine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000368	0.00204	CcSEcCtD
Halofantrine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000367	0.00203	CcSEcCtD
Halofantrine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000367	0.00203	CcSEcCtD
Halofantrine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00203	CcSEcCtD
Halofantrine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00203	CcSEcCtD
Halofantrine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00203	CcSEcCtD
Halofantrine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000365	0.00202	CcSEcCtD
Halofantrine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000362	0.00201	CcSEcCtD
Halofantrine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000362	0.00201	CcSEcCtD
Halofantrine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.002	CcSEcCtD
Halofantrine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.002	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000362	0.002	CcSEcCtD
Halofantrine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000362	0.002	CcSEcCtD
Halofantrine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000359	0.00199	CcSEcCtD
Halofantrine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.00199	CcSEcCtD
Halofantrine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000359	0.00199	CcSEcCtD
Halofantrine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000357	0.00198	CcSEcCtD
Halofantrine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00198	CcSEcCtD
Halofantrine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00197	CcSEcCtD
Halofantrine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000356	0.00197	CcSEcCtD
Halofantrine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00197	CcSEcCtD
Halofantrine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000356	0.00197	CcSEcCtD
Halofantrine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00196	CcSEcCtD
Halofantrine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00195	CcSEcCtD
Halofantrine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00195	CcSEcCtD
Halofantrine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00195	CcSEcCtD
Halofantrine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00035	0.00194	CcSEcCtD
Halofantrine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000349	0.00194	CcSEcCtD
Halofantrine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00193	CcSEcCtD
Halofantrine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00192	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00192	CcSEcCtD
Halofantrine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00191	CcSEcCtD
Halofantrine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000345	0.00191	CcSEcCtD
Halofantrine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000345	0.00191	CcSEcCtD
Halofantrine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000344	0.0019	CcSEcCtD
Halofantrine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000344	0.0019	CcSEcCtD
Halofantrine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.0019	CcSEcCtD
Halofantrine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000342	0.0019	CcSEcCtD
Halofantrine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.0019	CcSEcCtD
Halofantrine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00189	CcSEcCtD
Halofantrine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00189	CcSEcCtD
Halofantrine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00188	CcSEcCtD
Halofantrine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000339	0.00188	CcSEcCtD
Halofantrine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000339	0.00188	CcSEcCtD
Halofantrine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000339	0.00188	CcSEcCtD
Halofantrine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000337	0.00187	CcSEcCtD
Halofantrine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00186	CcSEcCtD
Halofantrine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00186	CcSEcCtD
Halofantrine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000336	0.00186	CcSEcCtD
Halofantrine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00185	CcSEcCtD
Halofantrine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000334	0.00185	CcSEcCtD
Halofantrine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000334	0.00185	CcSEcCtD
Halofantrine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00184	CcSEcCtD
Halofantrine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000332	0.00184	CcSEcCtD
Halofantrine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000332	0.00184	CcSEcCtD
Halofantrine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000331	0.00183	CcSEcCtD
Halofantrine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00183	CcSEcCtD
Halofantrine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00033	0.0993	CbGeAlD
Halofantrine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000329	0.00182	CcSEcCtD
Halofantrine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000328	0.00182	CcSEcCtD
Halofantrine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000328	0.00181	CcSEcCtD
Halofantrine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00181	CcSEcCtD
Halofantrine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000327	0.00181	CcSEcCtD
Halofantrine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00181	CcSEcCtD
Halofantrine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000327	0.00181	CcSEcCtD
Halofantrine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000326	0.0018	CcSEcCtD
Halofantrine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000326	0.0018	CcSEcCtD
Halofantrine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Halofantrine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Halofantrine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Halofantrine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.0018	CcSEcCtD
Halofantrine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000323	0.00179	CcSEcCtD
Halofantrine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000323	0.00179	CcSEcCtD
Halofantrine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000323	0.00179	CcSEcCtD
Halofantrine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00178	CcSEcCtD
Halofantrine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000321	0.00178	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00177	CcSEcCtD
Halofantrine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00032	0.00177	CcSEcCtD
Halofantrine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00032	0.00177	CcSEcCtD
Halofantrine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00175	CcSEcCtD
Halofantrine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.00175	CcSEcCtD
Halofantrine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00174	CcSEcCtD
Halofantrine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00173	CcSEcCtD
Halofantrine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000311	0.00172	CcSEcCtD
Halofantrine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00031	0.00172	CcSEcCtD
Halofantrine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00171	CcSEcCtD
Halofantrine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00171	CcSEcCtD
Halofantrine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000309	0.00171	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00171	CcSEcCtD
Halofantrine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.0017	CcSEcCtD
Halofantrine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00169	CcSEcCtD
Halofantrine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000304	0.00168	CcSEcCtD
Halofantrine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00168	CcSEcCtD
Halofantrine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.00168	CcSEcCtD
Halofantrine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00167	CcSEcCtD
Halofantrine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000302	0.00167	CcSEcCtD
Halofantrine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.00166	CcSEcCtD
Halofantrine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.00166	CcSEcCtD
Halofantrine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000299	0.00165	CcSEcCtD
Halofantrine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000298	0.0896	CbGeAlD
Halofantrine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00165	CcSEcCtD
Halofantrine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000297	0.00165	CcSEcCtD
Halofantrine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00163	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00163	CcSEcCtD
Halofantrine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00161	CcSEcCtD
Halofantrine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.0016	CcSEcCtD
Halofantrine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.0016	CcSEcCtD
Halofantrine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.0016	CcSEcCtD
Halofantrine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00159	CcSEcCtD
Halofantrine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00159	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00159	CcSEcCtD
Halofantrine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000285	0.00158	CcSEcCtD
Halofantrine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00158	CcSEcCtD
Halofantrine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000285	0.00158	CcSEcCtD
Halofantrine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.00157	CcSEcCtD
Halofantrine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00157	CcSEcCtD
Halofantrine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.00156	CcSEcCtD
Halofantrine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00155	CcSEcCtD
Halofantrine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.00155	CcSEcCtD
Halofantrine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00154	CcSEcCtD
Halofantrine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00154	CcSEcCtD
Halofantrine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000278	0.00154	CcSEcCtD
Halofantrine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00154	CcSEcCtD
Halofantrine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00153	CcSEcCtD
Halofantrine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00153	CcSEcCtD
Halofantrine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00151	CcSEcCtD
Halofantrine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.0015	CcSEcCtD
Halofantrine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.00149	CcSEcCtD
Halofantrine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00149	CcSEcCtD
Halofantrine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.00149	CcSEcCtD
Halofantrine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00148	CcSEcCtD
Halofantrine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00148	CcSEcCtD
Halofantrine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00147	CcSEcCtD
Halofantrine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00147	CcSEcCtD
Halofantrine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00147	CcSEcCtD
Halofantrine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00146	CcSEcCtD
Halofantrine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00146	CcSEcCtD
Halofantrine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00145	CcSEcCtD
Halofantrine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00144	CcSEcCtD
Halofantrine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00142	CcSEcCtD
Halofantrine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.00141	CcSEcCtD
Halofantrine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.0014	CcSEcCtD
Halofantrine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.0014	CcSEcCtD
Halofantrine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00139	CcSEcCtD
Halofantrine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00139	CcSEcCtD
Halofantrine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00138	CcSEcCtD
Halofantrine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00138	CcSEcCtD
Halofantrine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000249	0.00138	CcSEcCtD
Halofantrine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00138	CcSEcCtD
Halofantrine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00134	CcSEcCtD
Halofantrine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.00134	CcSEcCtD
Halofantrine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00133	CcSEcCtD
Halofantrine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.00133	CcSEcCtD
Halofantrine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00133	CcSEcCtD
Halofantrine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00132	CcSEcCtD
Halofantrine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00132	CcSEcCtD
Halofantrine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.00131	CcSEcCtD
Halofantrine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.00129	CcSEcCtD
Halofantrine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00128	CcSEcCtD
Halofantrine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00128	CcSEcCtD
Halofantrine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00126	CcSEcCtD
Halofantrine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.00125	CcSEcCtD
Halofantrine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00124	CcSEcCtD
Halofantrine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000224	0.0673	CbGeAlD
Halofantrine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00124	CcSEcCtD
Halofantrine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00123	CcSEcCtD
Halofantrine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00123	CcSEcCtD
Halofantrine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00122	CcSEcCtD
Halofantrine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00122	CcSEcCtD
Halofantrine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00022	0.0662	CbGeAlD
Halofantrine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00119	CcSEcCtD
Halofantrine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.00118	CcSEcCtD
Halofantrine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00118	CcSEcCtD
Halofantrine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.00118	CcSEcCtD
Halofantrine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00117	CcSEcCtD
Halofantrine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.00116	CcSEcCtD
Halofantrine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00114	CcSEcCtD
Halofantrine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00113	CcSEcCtD
Halofantrine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.00113	CcSEcCtD
Halofantrine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00112	CcSEcCtD
Halofantrine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.00111	CcSEcCtD
Halofantrine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.00106	CcSEcCtD
Halofantrine—KCNH2—blood—acquired immunodeficiency syndrome	0.000132	0.0398	CbGeAlD
Halofantrine—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000128	0.0385	CbGeAlD
Halofantrine—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000127	0.0383	CbGeAlD
Halofantrine—KCNH2—vagina—acquired immunodeficiency syndrome	0.000122	0.0369	CbGeAlD
Halofantrine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000121	0.0364	CbGeAlD
Halofantrine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000115	0.0345	CbGeAlD
Halofantrine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000112	0.0337	CbGeAlD
Halofantrine—CYP3A5—blood—acquired immunodeficiency syndrome	0.000109	0.0328	CbGeAlD
Halofantrine—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000107	0.0323	CbGeAlD
Halofantrine—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000103	0.0311	CbGeAlD
Halofantrine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000101	0.0304	CbGeAlD
Halofantrine—CYP3A5—lung—acquired immunodeficiency syndrome	9.57e-05	0.0288	CbGeAlD
Halofantrine—CYP3A4—digestive system—acquired immunodeficiency syndrome	8.6e-05	0.0259	CbGeAlD
Halofantrine—CYP2D6—digestive system—acquired immunodeficiency syndrome	8.46e-05	0.0255	CbGeAlD
Halofantrine—KCNH2—brain—acquired immunodeficiency syndrome	8.2e-05	0.0247	CbGeAlD
Halofantrine—CYP3A4—blood—acquired immunodeficiency syndrome	8.19e-05	0.0246	CbGeAlD
Halofantrine—CYP2D6—blood—acquired immunodeficiency syndrome	8.06e-05	0.0242	CbGeAlD
Halofantrine—KCNH2—lymph node—acquired immunodeficiency syndrome	7.92e-05	0.0238	CbGeAlD
Halofantrine—CYP2C8—brain—acquired immunodeficiency syndrome	7.5e-05	0.0226	CbGeAlD
Halofantrine—CYP3A4—nervous system—acquired immunodeficiency syndrome	6.65e-05	0.02	CbGeAlD
Halofantrine—CYP2D6—nervous system—acquired immunodeficiency syndrome	6.54e-05	0.0197	CbGeAlD
Halofantrine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	6.4e-05	0.0193	CbGeAlD
Halofantrine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	6.3e-05	0.019	CbGeAlD
Halofantrine—CYP2D6—brain—acquired immunodeficiency syndrome	5e-05	0.015	CbGeAlD
